Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.

Abstract:

:Background: Carbonic anhydrase 4 (CA4) maintains homeostasis of carbon dioxide and bicarbonate. It is suggested to be a potential prognostic biomarker, while the correlations between CA4 and different cancers are indistinct. Methods: Differential mRNA expression of CA4 among different cancers and corresponding normal tissues was compared based on datasets on the Cancer Genome Atlas (TCGA) platforms. Then, survival analysis was performed using Tumor-immune system interactionsplatform and TCGA cohort on the basis of distinct comparison expression of CA4 in five kinds of tumors. In addition, molecular penal analysis and functional annotations of CA4-related genes was elaborated. The correlation between CA4 mRNA expression and tumor immune microenvironment were analyzed in detail. Results: Compared with adjacent normal tissues, CA4 mRNA expressions were found significantly lower in various tumors. Moreover, decreased expression of CA4 was significantly related to worse overall survival (OS) and progression-free survival (PFS) in kidney renal clear cell carcinoma (KIRC), brain lower grade glioma (LGG), lung adenocarcinoma (LUAD) and uveal melanoma (UVM), and worse OS of prostate adenocarcinoma (PRAD) (p<0.05). Cox regression analyses indicated that CA4 was a significant prognostic biomarker in KIRC, LGG, LUAD and UVM. Moreover, CA4 showed markedly relationship with tumor immune environment and diverse immune infiltration signatures in KIRC, LGG, LUAD and UVM. Conclusions: Our study revealed that CA4 was a potential biomarker for aggressive progression and poor prognosis in KIRC, LGG, LUAD, PRAD and UVM, correlated with immune infiltration in various tumor environments. These results suggested that CA4 possibly served as a promising prognostic and immune infiltration biomarker in many cancers.

journal_name

J Cancer

journal_title

Journal of Cancer

authors

Xu Y,Xu WH,Shi SN,Yang XL,Ren YR,Zhuang XY,Qu YY,Zhang HL,Zhang XF

doi

10.7150/jca.46902

subject

Has Abstract

pub_date

2020-08-25 00:00:00

pages

6101-6113

issue

20

issn

1837-9664

pii

jcav11p6101

journal_volume

11

pub_type

杂志文章
  • Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells.

    abstract::Chemotherapy resistance represents a major obstacle for the treatment of patients with breast cancer (BC) and greatly restricts the therapeutic effect of the first-line chemotherapeutic agent doxorubicin (DOX). The present study aimed to investigate the feasibility of the recombinant dual-target murine double minute 2...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.32765

    authors: Fan Y,Ma K,Jing J,Wang C,Hu Y,Shi Y,Li E,Geng Q

    更新日期:2020-01-01 00:00:00

  • A Mathematical Model of Human Papillomavirus (HPV) in the United States and its Impact on Cervical Cancer.

    abstract:BACKGROUND:Mathematical models can be useful tools in exploring disease trends and health consequences of interventions in a population over time. Most cancers, in particular cervical cancer, have long incubation periods. The time from acquisition of HPV infection to development of invasive cancer can be up to two deca...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.4161

    authors: Lee SL,Tameru AM

    更新日期:2012-01-01 00:00:00

  • Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.

    abstract::Objectives: Chordomas are slow-growing malignancies that commonly affect vital neurological structures. These neoplasms are highly resistant to current chemotherapeutic regimens and often recur after surgical intervention. Therefore, there is an urgent need to identify molecular targets and more robust drugs to improv...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35426

    authors: Shen S,Dean DC,Yu Z,Hornicek F,Kan Q,Duan Z

    更新日期:2020-01-01 00:00:00

  • Gene Expression Detection Assay for Cancer Clinical Use.

    abstract::Cancer is a genetic disease where genetic variations cause abnormally functioning genes that appear to alter expression. Proteins, the final products of gene expression, determine the phenotypes and biological processes. Therefore, detecting gene expression levels can be used for cancer diagnosis, prognosis, and treat...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.24744

    authors: Narrandes S,Xu W

    更新日期:2018-06-05 00:00:00

  • Dysbindin facilitates invasion and metastasis by promoting phosphorylation of ERK in epithelial ovarian cancer.

    abstract::Dysbindin has been reported to be correlated with several malignancies. However, the clinical significance and biological role of dysbindin in epithelial ovarian cancer remains largely unknown. Here we demonstrated that the mRNA and protein levels of dysbindin were significantly upregulated in EOC tissues compared wit...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.39269

    authors: Lv X,Guo X,Ru Y,Zhou F,Yang X,Ge J,Li J,Liu S,Jiang K,Chen B

    更新日期:2020-02-21 00:00:00

  • Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.

    abstract::Colon cancer is one of the most common types of gastrointestinal cancers and the fourth cause of cancer death worldwide. To discover novel diagnostic biomarkers for colon cancer and investigate potential mechanisms of oncogenesis, quantitative proteomic approach using iTRAQ-tagging and 2D-LC-MS/MS was performed to cha...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.17192

    authors: Li G,Li M,Liang X,Xiao Z,Zhang P,Shao M,Peng F,Chen Y,Li Y,Chen Z

    更新日期:2017-02-11 00:00:00

  • Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer.

    abstract:PURPOSE:The aim of this study was to clarify the risk factors for discontinuing tegafur/gimeracil/oteracil potassium (S-1) adjuvant chemotherapy following gastrectomy in patients with gastric cancer. METHODS:We retrospectively investigated patients with curatively-resected gastric cancer who received S-1 adjuvant chem...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.11189

    authors: Kawazoe H,Shimasaki M,Ueno M,Sumikawa S,Takatori S,Namba H,Yoshida M,Sato K,Kojima Y,Watanabe Y,Moriguchi T,Tanaka A,Araki H

    更新日期:2015-03-18 00:00:00

  • Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation.

    abstract::Background: CDK 4 and 6 inhibitors (CDK4/6i), which arrest unregulated cancer cell proliferation, show clinical efficacy in breast cancer. Unexpectedly, a patient treated on a CDK4/6i-based trial, as first-line therapy in metastatic breast cancer, developed rapid disease progression following discontinuation of study ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.18196

    authors: Bashour SI,Doostan I,Keyomarsi K,Valero V,Ueno NT,Brown PH,Litton JK,Koenig KB,Karuturi M,Abouharb S,Tripathy D,Moulder-Thompson SL,Ibrahim NK

    更新日期:2017-07-05 00:00:00

  • Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.

    abstract::Objective: To enquire into the clinical significance and potential molecular mechanism of microRNA (miRNA)-196b-5p in hepatocellular carcinoma (HCC). Methods: Quantitative reverse transcription and polymerase chain reaction (qRT-PCR) were utilized to examine miR-196b-5p expression level in 67 HCC paraffin embedded tis...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.29293

    authors: Zhang L,Luo B,Dang YW,He RQ,Peng ZG,Chen G,Feng ZB

    更新日期:2019-08-29 00:00:00

  • Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes.

    abstract::Background: Colorectal cancer (CRC) remains to be one of the most common malignancies worldwide. Various studies have demonstrated that microRNAs (miRs) play a critical role in regulating cancer progression and sensitivity to chemoradiotherapy. miR-1 was found to be aberrantly expressed in CRC. However, it has not bee...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.44753

    authors: Wu Y,Pu N,Su W,Yang X,Xing C

    更新日期:2020-06-07 00:00:00

  • Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.

    abstract::Background and aims. Cyclin-dependent kinase inhibitor 3 (CDKN3) has been found playing a varying role in carcinogenesis, but its biological function in esophageal squamous cell carcinoma (ESCC) is unclear. The aim of this study was to demonstrate the role of CDKN3 in ESCC. Materials and Methods: Real-time PCR and Wes...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.27053

    authors: Liu J,Min L,Zhu S,Guo Q,Li H,Zhang Z,Zhao Y,Xu C,Zhang S

    更新日期:2019-04-21 00:00:00

  • Long noncoding RNA LINC01391 restrained gastric cancer aerobic glycolysis and tumorigenesis via targeting miR-12116/CMTM2 axis.

    abstract::Increasing studies indicate that long noncoding RNA (lncRNA) plays a critical role in aerobic glycolysis of various tumors. However, the contribution of lncRNA in gastric cancer (GC) cell glycolysis is still poorly understood. The objective of this research was to investigate the functional role and mechanism of lncRN...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.48365

    authors: Qian C,Xu Z,Chen L,Wang Y,Yao J

    更新日期:2020-08-27 00:00:00

  • The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy.

    abstract::Background: The programmed death 1 (PD1)/programmed death ligand 1 (PDL1) targeted therapies have gained positive outcomes in several tumors, but the evidence of the expression and prognosis value of PD1/PDL1 in high risk prostate cancer was rare. Methods: Immunohistochemical analysis of PDL1/PD1 expression by a valid...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.30384

    authors: Li H,Wang Z,Zhang Y,Sun G,Ding B,Yan L,Liu H,Guan W,Hu Z,Wang S,Cheng F,Xu H,Zhang X,Ye Z

    更新日期:2019-06-02 00:00:00

  • Intraoperative Diagnosis and Surgical Procedure with Imprint Cytology for Small Pulmonary Adenocarcinoma.

    abstract::Objectives: For patients with multiple small-sized pulmonary cancers, a lobectomy can disrupt future therapeutic options for other lesions. It was recently reported that limited pulmonary resections were not inferior to lobectomy for the management of selected peripheral small-sized pulmonary adenocarcinomas. Patients...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35026

    authors: Nakagiri T,Nakayama T,Tokunaga T,Takenaka A,Kunoh H,Ishida H,Tomita Y,Nakatsuka SI,Nakamura H,Okami J,Higashiyama M

    更新日期:2020-02-20 00:00:00

  • Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.

    abstract::Tumor progression is often associated with chronic inflammation in the tumor microenvironment, which is mediated by numerous cytokines, chemokines and growth factors produced by cancer and stroma cells. All these mediators support tumor development and immunosuppression in autocrine and/or paracrine ways. Neutralizati...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.5047

    authors: Sevko A,Umansky V

    更新日期:2013-01-01 00:00:00

  • Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population.

    abstract::Colorectal cancer (CRC) is considered to be closely associated with alteration of intestinal microorganisms. The purpose of present study was to investigate the distribution of gut microbiota in the distinction of microbiota dysbiosis between two disease syndromes called Zheng-Qi-Kui-Xu(ZQKX) and Xie-Du-Yong-Sheng (XD...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.50318

    authors: Wang P,Ding S,Sun L,Feng Y,Guo K,Zhu Y,Huang D,Ruan S

    更新日期:2020-10-23 00:00:00

  • Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC.

    abstract::Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used to treat non-small cell lung cancer (NSCLC) because they inhibit tumour growth and metastasis. However, the underlying mechanisms are not fully understood. Here, we investigate whether anti-lymphangiogenesis mechanisms cont...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35448

    authors: Zhang Y,Yang X,Liu H,Cai M,Shentu Y

    更新日期:2020-01-01 00:00:00

  • New Prospect for Cancer Cachexia: Medical Cannabinoid.

    abstract::Cachexia is a common term for the wasting symptoms which may appear in almost every chronic illness, such as AIDS, tuberculosis, and cancer. Cancer cachexia (CCA) is a result of the interaction between the host and the tumor, mainly manifested in short-term wasting, malnutrition, and so on. Due to the chronic food sho...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.28246

    authors: Wang J,Wang Y,Tong M,Pan H,Li D

    更新日期:2019-01-01 00:00:00

  • The role and function of PPARγ in bladder cancer.

    abstract::Peroxisome proliferator-activated receptor gamma (PPARγ), a member of the nuclear receptor superfamily, participates in multiple physiological and pathological processes. Extensive studies have revealed the relationship between PPARγ and various tumors. However, the expression and function of PPARγ in bladder cancer s...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.42663

    authors: Peng T,Wang G,Cheng S,Xiong Y,Cao R,Qian K,Ju L,Wang X,Xiao Y

    更新日期:2020-04-06 00:00:00

  • Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.

    abstract:PURPOSE:Triple-negative breast cancer (TNBC) has attracted more attention both clinically and experimentally because of its high-risk biological characteristics and lacking of effective treatment method. The purpose of this retrospective study was to find out the incidence of triple-negative breast cancer (TNBC) in all...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.10944

    authors: Qiu J,Xue X,Hu C,Xu H,Kou D,Li R,Li M

    更新日期:2016-01-01 00:00:00

  • Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases.

    abstract::Background: To investigate the relationship between clinical and histopathological characteristics and overall survival of patients with oral mucosal melanoma (OMM) without distal metastasis in order to provide predictive prognostic information of OMM. Methods: Ki67 expression was assessed by immunohistochemistry in 1...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20935

    authors: Ma X,Wu Y,Zhang T,Song H,Jv H,Guo W,Ren G

    更新日期:2017-10-17 00:00:00

  • Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma.

    abstract::Background: Hepatitis B virus infection had been identified its relationship with liver diseases, including liver tumors. We aimed to explore diagnostic and prognostic values between the Human Leukocyte Antigen (HLA) complex and hepatocellular carcinoma (HCC). Methods: We used the GSE14520 dataset to explore diagnosti...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.29655

    authors: Wang XK,Liao XW,Yang CK,Yu TD,Liu ZQ,Gong YZ,Huang KT,Zeng XM,Han CY,Zhu GZ,Qin W,Peng T

    更新日期:2019-08-28 00:00:00

  • Surgery plus chemotherapy improves survival of patients with extremity soft tissue leiomyosarcoma and metastasis at presentation.

    abstract::Purpose: Extremity soft tissue leiomyosarcoma (LMS) with metastasis is a rare disease with a poor prognosis. The purpose of our study was to define clinical features of extremity soft tissue LMS with metastasis as well as to identify multivariable predictors of survival. Methods: During 1973-2015, 239 patients with me...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.29874

    authors: Qian SJ,Wu JQ,Wang Z,Zhang B

    更新日期:2019-05-21 00:00:00

  • Blood-based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Pancreatic Cancer and its Value to Guide Clinical Treatment.

    abstract::Objective: Pancreatic cancer (PC) is a malignant tumor with limited therapeutic choices and extremely poor prognosis. Personalized therapy based on gene alternations is a promising choice. Considering tumor heterogeneity, the practice of ctDNA analysis has drawn the attention. Here, we try to assess the applicability ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.43087

    authors: Li H,Di Y,Li J,Jiang Y,He H,Yao L,Gu J,Lu J,Song J,Chen S,Cai S,Jin C,Yuan Z,Fu D

    更新日期:2020-04-27 00:00:00

  • The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature.

    abstract:BACKGROUND:MALAT-1 is significantly overexpressed in various cancers, suggesting that it might be a potential biomarker of cancer. METHODS:A meta-analysis was performed using microarray data obtained via the Affymetrix Human Genome U133 Plus 2.0 platform found in the Gene Expression Omnibus (GEO) database and data obt...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.14663

    authors: Wang Y,Xue D,Li Y,Pan X,Zhang X,Kuang B,Zhou M,Li X,Xiong W,Li G,Zeng Z,Yang T

    更新日期:2016-05-20 00:00:00

  • Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.

    abstract:: Purpose: Differentiated thyroid cancer (DTC) accounts for approximately 95% of thyroid carcinomas. In the metastatic RAI-refractory disease, chemotherapy has very limited efficacy and is associated with substantial toxicity. With increasing knowledge of the molecular patho...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.22318

    authors: Balmelli C,Railic N,Siano M,Feuerlein K,Cathomas R,Cristina V,Güthner C,Zimmermann S,Weidner S,Pless M,Stenner F,Rothschild SI

    更新日期:2018-01-01 00:00:00

  • Role of Endometrial Autophagy in Physiological and Pathophysiological Processes.

    abstract::Endometrium is the mucosal lining of the uterus which expressed a cyclic process of proliferation, secretion and scaling under the control of hormones secreted by the ovary, and it also plays an indispensable role in the embryo implantation, the constitution of fetal-maternal interface, and the maintaining of pregnanc...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.31742

    authors: Yang S,Wang H,Li D,Li M

    更新日期:2019-06-09 00:00:00

  • Long-term aspirin use for primary cancer prevention: An updated systematic review and subgroup meta-analysis of 29 randomized clinical trials.

    abstract::Background and objective: Long-term aspirin use for the primary prevention of cancer remains controversial, and variations in the effect of aspirin use on cancer outcomes by aspirin dose, follow-up duration, or study population have never been systematically evaluated. The objective of this study was to evaluate the e...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.49001

    authors: Wu Q,Yao X,Chen H,Liu Z,Li T,Fan X,Zhang G,Yu L,Chen M,Xu C,Zhang R,Chen B,Sui X,Leung EL

    更新日期:2020-09-14 00:00:00

  • Increased Reactive Oxygen Species and Distinct Oxidative Damage in Resveratrol-suppressed Glioblastoma Cells.

    abstract::Background and Aim: Glioblastoma multiforme (GBM) is a highly aggressive brain malignancy that lacks reliable treatments. Resveratrol possesses anti-cancer effects, but its activity against glioblastoma cells is variable for unknown reasons. One mechanism through which anti-cancer drugs exert their effects is oxidativ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.45489

    authors: Jia B,Zheng X,Wu ML,Tian XT,Song X,Liu YN,Li PN,Liu J

    更新日期:2021-01-01 00:00:00

  • Prognostic and Clinicopathological Significance of lncRNA MVIH in Cancer Patients.

    abstract::Objectives: LncRNA associated with microvascular invasion in hepatocellular carcinoma (lncRNA MVIH) is a newly discovered long non-coding RNA that aberrantly up-regulates and holds prognostic value in various tumors. The aim of the review and meta-analysis is to assess its prognostic potential and functions in maligna...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28541

    authors: Zhang Y,Lin S,Yang X,Zhang X

    更新日期:2019-02-26 00:00:00